Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Prewitt

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Chest|August 1, 1991
Effect of low-molecular-weight heparin on recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolismJ Werier, J Ducas, S Gu, et al.
Chest|June 1, 1992
Coronary thrombolysis. Comparative effects of intracoronary administration of recombinant tissue plasminogen activator and urokinaseS Gu, J Ducas, J N Patton, et al.
Chest|September 1, 1985
Effects of noradrenaline and isoproterenol on cardiopulmonary function in a canine model of acute pulmonary hypertensionD W Molloy, K Y Lee, D Jones, et al.
The American Review of Respiratory Disease|November 1, 1984
Treatment of shock in a canine model of pulmonary embolismW D Molloy, K Y Lee, L Girling, et al.
Chest|July 1, 1991
Coronary thrombolysis with recombinant tissue plasminogen activator. Intracoronary vs intravenous administrationS A Gu, J Ducas, K Wolfe, et al.
Chest|June 1, 1989
The cardiopulmonary and renal hemodynamic effects of norepinephrine in canine pulmonary embolismM R Angle, D W Molloy, B Penner, et al.
The American Review of Respiratory Disease|September 1, 1984
Effects of dopamine on cardiopulmonary function and left ventricular volumes in patients with acute respiratory failureW D Molloy, K Dobson, L Girling, et al.
Chest|March 1, 1991
Effects of hydralazine and increased cardiac output on recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolismR M Prewitt, A M Downes, S A Gu, et al.
The American Review of Respiratory Disease|November 1, 1983
Treatment of canine low pressure pulmonary edema. Nitroprusside versus hydralazineW D Harrison, M Raizen, M Ghignone, et al.
Circulation|July 1, 1988
Treatment of canine embolic pulmonary hypertension with recombinant tissue plasminogen activator. Efficacy of dosing regimesF Shiffman, J Ducas, P Hollett, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Chest|August 1, 1991
Effect of low-molecular-weight heparin on recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolismJ Werier, J Ducas, S Gu, et al.
Chest|June 1, 1992
Coronary thrombolysis. Comparative effects of intracoronary administration of recombinant tissue plasminogen activator and urokinaseS Gu, J Ducas, J N Patton, et al.
Chest|September 1, 1985
Effects of noradrenaline and isoproterenol on cardiopulmonary function in a canine model of acute pulmonary hypertensionD W Molloy, K Y Lee, D Jones, et al.
The American Review of Respiratory Disease|November 1, 1984
Treatment of shock in a canine model of pulmonary embolismW D Molloy, K Y Lee, L Girling, et al.
Chest|July 1, 1991
Coronary thrombolysis with recombinant tissue plasminogen activator. Intracoronary vs intravenous administrationS A Gu, J Ducas, K Wolfe, et al.
Chest|June 1, 1989
The cardiopulmonary and renal hemodynamic effects of norepinephrine in canine pulmonary embolismM R Angle, D W Molloy, B Penner, et al.
The American Review of Respiratory Disease|September 1, 1984
Effects of dopamine on cardiopulmonary function and left ventricular volumes in patients with acute respiratory failureW D Molloy, K Dobson, L Girling, et al.
Chest|March 1, 1991
Effects of hydralazine and increased cardiac output on recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolismR M Prewitt, A M Downes, S A Gu, et al.
The American Review of Respiratory Disease|November 1, 1983
Treatment of canine low pressure pulmonary edema. Nitroprusside versus hydralazineW D Harrison, M Raizen, M Ghignone, et al.
Circulation|July 1, 1988
Treatment of canine embolic pulmonary hypertension with recombinant tissue plasminogen activator. Efficacy of dosing regimesF Shiffman, J Ducas, P Hollett, et al.
Pageof 6